Browse

You are looking at 1 - 10 of 3,845 items for

  • Refine by Content Type: All x
Clear All Modify Search

Temperature changes, shifting precipitation patterns, and increasing vector-human contact have led to a wider prevalence of kidney diseases across the world.

ASN supports accelerated manufacturing and distribution of monoclonal antibodies for COVID-19 that provide additional prophylactic benefit to immunocompromised populations.

Kenar Jhaveri and Mayuri Trivedi